13F
中

BOLD BOUNDLESS BIO INC

2026Q1 · CUSIP 10170A100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
35
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
19
Δ whales
0
Inst. holding value
$9M
New positions
7
Closed positions
8
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2024Q2: Δ+4 · h=47 2024Q3: Δ+8 · h=55 2024Q4: Δ+1 · h=56 2025Q1: Δ-1 · h=55 2025Q2: Δ-10 · h=45 2025Q3: Δ-10 · h=35 2025Q4: Δ+1 · h=36 2026Q1: Δ-1 · h=35 2024Q2: holders=47 2024Q3: holders=55 2024Q4: holders=56 2025Q1: holders=55 2025Q2: holders=45 2025Q3: holders=35 2025Q4: holders=36 2026Q1: holders=35 -10 -5 +0 +5 +10 314559 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.49
EPS YoY
-132.3%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-06-30: EPS -0.77 2024-09-30: EPS -0.74 2025-03-31: EPS -0.71 2025-06-30: EPS -0.70 2025-09-30: EPS -0.62 2025-12-31: EPS -0.57 2026-03-31: EPS -0.60 -0.85 -0.42 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)